US AI In Oncology Market Size, Share and Trends Analysis
The US AI in Oncology market reached $1.8 billion in 2023 and is projected to grow at a 28.5% CAGR, reaching $15.1 billion by 2032. Explore key trends, segmentations, and leading players.
Revenue, 2023
$1.8B
Forecast, 2032
$15.1B
CAGR, 2024-2032
28.5%
Report Coverage
North America
Market Overview
The US AI in Oncology market is experiencing rapid growth with a current valuation of $1.8 billion, driven by advances in machine learning and increasing adoption of precision oncology solutions, projected to reach $15.1 billion by 2032 at a robust 28.5% CAGR.
Market Stage
Early growth
Adoption Level
Growing
Key Trends
Market Forecast & Data
Base Year (2023)
$2.3B
Forecast (2032)
$15.1B
CAGR (2024-2032)
28.5%
North America
#1Largest market: United States
Europe
#2Largest market: Germany
Market Dynamics
- Rising cancer incidence rates requiring more efficient diagnostic workflows
- Regulatory frameworks enabling AI medical device approvals
- Increasing availability of structured clinical data for algorithm training
- Demand for cost-effective precision oncology solutions
Market Segmentation
By Application
- Diagnostic Imaging Analysis
- Treatment Planning & Personalization
- Drug Discovery & Development
- Clinical Decision Support
By End User
- Hospitals & Academic Medical Centers
- Specialized Oncology Clinics
- Pharmaceutical Companies
- Research Institutions
Regional Analysis
North America
Lead: United StatesDominates the global market due to advanced healthcare infrastructure, strong venture capital investment, and early adoption of AI technologies in oncology.
Europe
Lead: GermanyGrowing market driven by digital health initiatives and strong regulatory frameworks supporting AI in healthcare.
Asia Pacific
Lead: ChinaFastest-growing region with significant government investment in AI healthcare solutions and expanding oncology care infrastructure.
Country-Level Analysis
| Country | Share | Growth |
|---|---|---|
| United States | 65.2% | +29.1% |
| Germany | 12.3% | +24.1% |
| China | 8.7% | +35.4% |
| United Kingdom | 6.9% | +22.8% |
Competitive Landscape
PathAI
Boston, USA
Specializes in AI-powered pathology solutions for cancer diagnosis and treatment response prediction
Tempus
Chicago, USA
Develops AI platforms integrating genomic and clinical data for precision oncology
IBM Watson Health
Armonk, USA
Offers AI solutions for oncology treatment planning and clinical trial matching
Enlitic
San Francisco, USA
Provides AI-powered medical imaging solutions for cancer detection
Oncora Medical
Boston, USA
Focuses on AI-driven treatment planning for radiation oncology
Recent Developments
Launch of new AI module for predicting immunotherapy response in melanoma
FDA clearance for AI-driven radiation therapy planning solution
FDA clearance for AI-powered breast cancer diagnosis platform
Partnership with Mayo Clinic for AI-driven treatment planning in lung cancer
Integration of AI with cloud-based imaging platforms for radiology workflow optimization